Generic Name and Formulations:
Pindolol 5mg, 10mg; tabs.
Various generic manufacturers
Indications for Pindolol:
Initially 5mg twice daily. May increase after 3–4 wks in 10mg increments; max 60mg daily.
Asthma. Severe bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock.
Severe COPD. Ischemic heart disease or failure. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Surgery. Avoid abrupt cessation. Pregnancy (Cat.B). Nursing mothers: not recommended.
Hypotension with prazosin, reserpine. Adjust antidiabetic medications. Caution with verapamil, catecholamine-depleting drugs. May block epinephrine, β-agonists. Potentiated by thioridazine.
Muscle pain, insomnia, dizziness, fatigue, anxiety, joint pain, edema, dyspnea, GI upset, paresthesias, chest pain, pruritus, bradycardia, bronchospasm, heart failure or block, angina.
Formerly known under the brand name Visken.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Breast Implant-Associated Anaplastic Large Cell Lymphoma — In the Clinic
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- 5α-Reductase Inhibitors Do Not Increase Risk of High-Grade Prostate Cancer
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC
- Model May Identify Patients With Gastric Cancer Likely To Benefit From Chemotherapy